| http://www.w3.org/ns/prov#value | - Given the ever-evolving landscape of clinical drug testing, Dr. Snyder says laboratory directors will need to come up with a way of providing real-time updates regarding the current characteristics of their toxicology testing, including drugs detected, analytical cutoffs, and possible interferences and limitations for each method. ???This may be accomplished in the form of regularly scheduled meet
|
